GAMMA Investing’s Editas Medicine EDIT Stock Holding History

GAMMA Investing’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.41K	Buy	2,103 +821	+64%	+$2.41K	﹤0.01%	3614
2026 Q2	$4.15K	Buy	1,282 +82	+7%	+$240	﹤0.01%	3549
2026 Q1	$2.96K	Buy	1,200 +652	+119%	+$1.38K	﹤0.01%	3551
2025 Q4	$1.12K	Buy	+548	New	+$1.58K	﹤0.01%	3757
2024 Q4	–	Sell	-137	Closed	-$467	–	3792
2024 Q3	$467	Sell	137 -1,381	-91%	-$6.01K	﹤0.01%	3404
2024 Q2	$7.09K	Buy	1,518 +793	+109%	+$4.47K	﹤0.01%	2415
2024 Q1	$5.38K	Buy	725 +176	+32%	+$1.46K	﹤0.01%	2381
2023 Q4	$3.86K	Buy	+549	New	+$4.82K	﹤0.01%	2345

Other funds holding EDIT

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's EDIT Position: Q3 2026 in Review

GAMMA Investing increased its Editas Medicine (EDIT) stake by 64% in Q3 2026, buying an estimated $2.41K and bringing the position to 2,103 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3614.

GAMMA Investing first reported a position in EDIT in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.09K in Q2 2024. 7 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

GAMMA Investing held 2,103 shares of Editas Medicine worth $5.41K as of Q3 2026.
GAMMA Investing bought 821 Editas Medicine shares in Q3 2026, an estimated $2.41K.
Editas Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3614 holding.
GAMMA Investing first reported a position in Editas Medicine in Q4 2023 and has held it in 8 quarters since.
GAMMA Investing's Editas Medicine position peaked at $7.09K in Q2 2024.
7 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.